Xin Lang Cai Jing·2026-03-27 06:53Core Viewpoint - Tiger Med has seen a 5% increase in stock price, reaching 53.32 CNY per share, with a total market capitalization of 45.91 billion CNY, and a cumulative increase of 6.82% over three consecutive days [1][5]. Company Overview - Tiger Med, established on December 15, 2004, and listed on August 17, 2012, is located in Hangzhou, Zhejiang Province. The company specializes in providing professional clinical research services for domestic and international pharmaceutical and health-related products [1][5]. - The main business activities include I to IV phase clinical trial technical services, data management and statistical analysis, registration application, on-site clinical trial services, SMO services, medical testing services, medical documentation translation, medical imaging diagnosis services, and training services [1][5]. - The revenue composition of the main business is as follows: clinical trial-related services and laboratory services account for 52.60%, clinical trial technical services for 45.21%, and other services for 2.19% [1][5]. Shareholder Insights - The Huabao CSI Medical ETF (512170) is among the top ten circulating shareholders of Tiger Med, having reduced its holdings by 2.11% to 14.568 million shares in the third quarter, resulting in a floating profit of approximately 37.03 million CNY today [2][6]. - Over the three-day increase, the floating profit for the ETF has reached 47.20 million CNY [2][6]. Fund Performance - The Huabao CSI Medical ETF (512170) was established on May 20, 2019, with a current scale of 25.26 billion CNY. It has experienced a loss of 6.22% this year, ranking 4644 out of 5563 in its category [7]. - The fund manager, Zhang Fang, has been in position for 5 years and 59 days, with the fund's total assets amounting to 35.43 billion CNY. The best return during his tenure is 57.19%, while the worst is -23.7% [3][7]. Fund Holdings - The Huabao CSI Medical ETF (512170) increased its holdings in Tiger Med by 126.14 million shares in the fourth quarter, now holding 15.8293 million shares, which constitutes 3.55% of the fund's net value, making it the sixth-largest holding [4][8]. - The floating profit from this position today is approximately 40.21 million CNY, with a total floating profit of 51.29 million CNY over the three-day increase [4][8].